Pierre Giglio to Humans
This is a "connection" page, showing publications Pierre Giglio has written about Humans.
Connection Strength
0.386
-
Early assessment of recurrent glioblastoma response to bevacizumab treatment by diffusional kurtosis imaging: a preliminary report. Neuroradiol J. 2019 Oct; 32(5):317-327.
Score: 0.025
-
Spinal Cord Toxicity from Intrathecal Chemotherapy: A Case with Clinicopathologic Correlation. World Neurosurg. 2019 Aug; 128:381-384.
Score: 0.025
-
Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma. Cancer. 2012 Jul 15; 118(14):3599-606.
Score: 0.015
-
Metastatic hepatocellular carcinoma with associated spinal cord compression. Am J Med Sci. 2011 Feb; 341(2):148-52.
Score: 0.014
-
Neurologic complications of cancer and its treatment. Curr Oncol Rep. 2010 Jan; 12(1):50-9.
Score: 0.013
-
Neurologic complications of non-Hodgkin's lymphoma. Curr Hematol Malig Rep. 2006 Dec; 1(4):214-9.
Score: 0.011
-
Syncope and head CT scans in the emergency department. Emerg Radiol. 2005 Dec; 12(1-2):44-6.
Score: 0.010
-
Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma. Hematol Oncol Clin North Am. 2005 Aug; 19(4):597-609, v.
Score: 0.010
-
Neoplastic meningitis in patients with adenocarcinoma of the gastrointestinal tract. Cancer. 2005 Jun 01; 103(11):2355-62.
Score: 0.010
-
The primary parasomnias. A review for neurologists. Neurologist. 2005 Mar; 11(2):90-7.
Score: 0.009
-
Neurologic complications of non-Hodgkin's lymphoma. Curr Oncol Rep. 2005 Jan; 7(1):61-5.
Score: 0.009
-
Case 3: kicking, yelling and sleeping. MedGenMed. 2004 Oct 05; 6(4):43.
Score: 0.009
-
Case 2: an irresistible urge to sleep. MedGenMed. 2004 Aug 31; 6(3):45.
Score: 0.009
-
Cyclooxygenase-2 inhibitors in glioma therapy. Am J Ther. 2004 Mar-Apr; 11(2):141-3.
Score: 0.009
-
Response of neoplastic meningitis from solid tumors to oral capecitabine. J Neurooncol. 2003 Nov; 65(2):167-72.
Score: 0.009
-
Cerebral radiation necrosis. Neurologist. 2003 Jul; 9(4):180-8.
Score: 0.008
-
Toxic epidermal necrolysis due to administration of celecoxib (Celebrex). South Med J. 2003 Mar; 96(3):320-1.
Score: 0.008
-
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial. JAMA Oncol. 2023 01 01; 9(1):112-121.
Score: 0.008
-
Translational landscape of glioblastoma immunotherapy for physicians: guiding clinical practice with basic scientific evidence. J Hematol Oncol. 2022 06 11; 15(1):80.
Score: 0.008
-
Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study. Clin Cancer Res. 2022 06 01; 28(11):2270-2277.
Score: 0.008
-
Bioethical implications of current state practices of molecular diagnostics in neuropathology. Neuro Oncol. 2022 06 01; 24(6):853-854.
Score: 0.008
-
Phase I study of trametinib in combination with whole brain radiation therapy for brain metastases. Radiother Oncol. 2022 05; 170:21-26.
Score: 0.008
-
Dose-escalated accelerated hypofractionation for elderly or frail patients with a newly diagnosed glioblastoma. J Neurooncol. 2022 Jan; 156(2):399-406.
Score: 0.008
-
Primary central nervous system lymphoma masquerading as herpes encephalitis: clinical, magnetic resonance imaging, and pathologic findings. Am J Med Sci. 2002 Jan; 323(1):59-61.
Score: 0.008
-
Targeted Therapy for BRAF Mutant Brain Tumors. Curr Treat Options Oncol. 2021 10 06; 22(11):105.
Score: 0.007
-
Intraoperative 3?T MRI is more correlative to residual disease extent than early postoperative MRI. J Neurooncol. 2021 Sep; 154(3):345-351.
Score: 0.007
-
Impact of cerebrospinal fluid flow study in patients undergoing intrathecal chemotherapy via ventricular catheter reservoir. J Neurooncol. 2021 May; 153(1):161-167.
Score: 0.007
-
Management of gliomas in patients with Lynch syndrome. Neuro Oncol. 2021 01 30; 23(1):167-168.
Score: 0.007
-
Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomas. PLoS One. 2020; 15(12):e0244383.
Score: 0.007
-
False-positive 1p/19q Testing Results in Gliomas: Clinical and Research Consequences. Am J Clin Oncol. 2020 11; 43(11):802-805.
Score: 0.007
-
A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma. Neuro Oncol. 2020 10 14; 22(10):1505-1515.
Score: 0.007
-
Changing paradigms for targeted therapies against diffuse infiltrative gliomas: tackling a moving target. Expert Rev Neurother. 2019 07; 19(7):663-677.
Score: 0.006
-
Single agent efficacy of the HDAC inhibitor DATS in preclinical models of glioblastoma. Cancer Chemother Pharmacol. 2018 12; 82(6):945-952.
Score: 0.006
-
Perilesional apparent diffusion coefficient in the preoperative evaluation of glioma grade. Clin Imaging. 2018 Nov - Dec; 52:88-94.
Score: 0.006
-
A novel component from citrus, ginger, and mushroom family exhibits antitumor activity on human meningioma cells through suppressing the Wnt/?-catenin signaling pathway. Tumour Biol. 2015 Sep; 36(9):7027-34.
Score: 0.005
-
Mechanisms and clinical significance of histone deacetylase inhibitors: epigenetic glioblastoma therapy. Anticancer Res. 2015 Feb; 35(2):615-25.
Score: 0.005
-
Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma. Neuro Oncol. 2015 Feb; 17(2):266-73.
Score: 0.005
-
Multi-targeted DATS prevents tumor progression and promotes apoptosis in ectopic glioblastoma xenografts in SCID mice via HDAC inhibition. J Neurooncol. 2013 Aug; 114(1):43-50.
Score: 0.004
-
Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma. Metab Brain Dis. 2013 Sep; 28(3):355-66.
Score: 0.004
-
Drug resistance in glioblastoma: a mini review. Neurochem Res. 2012 Jun; 37(6):1192-200.
Score: 0.004
-
Neurological deficits during treatment with tumor necrosis factor-alpha antagonists. Am J Med Sci. 2011 Nov; 342(5):352-5.
Score: 0.004
-
Glioneuronal tumor with neuropil-like islands of the spinal cord with diffuse leptomeningeal neuraxis dissemination. J Neurooncol. 2011 Sep; 104(2):529-33.
Score: 0.004
-
Concomitant lymphoma and cryptococcosis in a patient with acquired immune deficiency syndrome. Am J Med Sci. 2010 Oct; 340(4):340-2.
Score: 0.003
-
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma. Neuro Oncol. 2010 Nov; 12(11):1167-72.
Score: 0.003
-
High-dose radiotherapy to 78 Gy with or without temozolomide for high grade gliomas. J Neurooncol. 2009 Jul; 93(3):343-8.
Score: 0.003
-
Agrypnia excitata: current concepts and future prospects in management. J Neuropsychiatry Clin Neurosci. 2009; 21(2):126-31.
Score: 0.003
-
Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme. Neuro Oncol. 2008 Apr; 10(2):216-22.
Score: 0.003
-
Brain tumors in individuals with familial adenomatous polyposis: a cancer registry experience and pooled case report analysis. Cancer. 2007 Feb 15; 109(4):761-6.
Score: 0.003
-
Case files from the University of Chicago's Sleep Disorders Center. Case 1: a gigantic fatigue. MedGenMed. 2004 Apr 02; 6(2):50.
Score: 0.002
-
Hyperkinetic seizures in children. J Child Neurol. 2003 Aug; 18(8):517-24.
Score: 0.002
-
Paraneoplastic chorea: case study with autopsy confirmation. Neuro Oncol. 2002 07; 4(3):192-5.
Score: 0.002
-
Diffuse magnetic resonance imaging white-matter changes in a 15-year-old boy with mitochondrial encephalomyopathy. J Child Neurol. 2002 Jan; 17(1):47-9.
Score: 0.002